Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer-Reference-Cited by-同舟云学术

Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer

Published:2018-06-19 Issue:6 Volume:14 Page:e1006192
ISSN:1553-7358
Container-title:PLOS Computational Biology
language:en
Short-container-title:PLoS Comput Biol

Author:

Shin Sung-Young,Müller Anna-Katharina,Verma Nandini,Lev Sima,Nguyen Lan K.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modeling and Simulation,Ecology, Evolution, Behavior and Systematics

Reference61 articles.

1. Combination therapies in oncology;RM Webster;Nature reviews Drug discovery,2016

2. Feedback regulation in cell signalling: Lessons for cancer therapeutics;LK Nguyen;Semin Cell Dev Biol,2016

3. Feedback regulation in cell signalling: Lessons for cancer therapeutics;LK Nguyen;Seminars in cell & developmental biology,2015

4. Dynamics of ubiquitin-mediated signalling: insights from mathematical modelling and experimental studies;LK Nguyen;Briefings in bioinformatics,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer;Cancer Letters;2024-04

2. Integrative modeling and analysis of signaling crosstalk reveal molecular switches coordinating Yes-associated protein transcriptional activities;iScience;2024-03

3. Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer;npj Precision Oncology;2024-01-26

4. New Directions in Systems Biology-based Target Identification and Cancer Genome Analysis;Cheminformatics and Bioinformatics at the Interface with Systems Biology;2023-09-08

5. PYK2, a hub of signaling networks in breast cancer progression;Trends in Cell Biology;2023-08